Biomerica (BMRA) Share-based Compensation Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -35.57% |
| Nov 30, 2025 | -32.03% |
| Aug 31, 2025 | 103.53% |
| May 31, 2025 | -20.76% |
| Feb 28, 2025 | -10.44% |
| Nov 30, 2024 | 39.70% |
| Aug 31, 2024 | 67.44% |
| May 31, 2024 | 112.48% |
| Feb 29, 2024 | 19.87% |
| Nov 30, 2023 | 159.24% |
| Aug 31, 2023 | 83.89% |
| May 31, 2023 | 88.38% |
| Feb 28, 2023 | 127.49% |
| Nov 30, 2022 | 320.81% |
| Aug 31, 2022 | 133.46% |
| May 31, 2022 | 91.35% |
| Feb 28, 2022 | 105.99% |
| Nov 30, 2021 | 86.81% |
| Aug 31, 2021 | 350.63% |
| May 31, 2021 | 101.25% |
| Feb 28, 2021 | 86.24% |
| Nov 30, 2020 | 193.73% |
| Aug 31, 2020 | 67.13% |
| May 31, 2020 | 144.54% |
| Feb 29, 2020 | 105.99% |
| Nov 30, 2019 | 105.70% |
| Aug 31, 2019 | 42.01% |
| Feb 28, 2019 | 68.48% |
| Aug 31, 2018 | 55.79% |
| May 31, 2018 | 15.26% |
| May 31, 2017 | -13.11% |
| Feb 28, 2017 | -14.25% |
| May 31, 2016 | -26.13% |
| Feb 29, 2016 | 26.25% |